PURE Bioscience raises $555,000 in private share placement
PURE•PURE Bioscience raised $555,000 by selling 10,183,486 unregistered common shares at $0.0545 each, with director Tom Y. Lee investing the full amount directly and through affiliates.
1. Placement details
The private placement closed on October 15, 2026. PURE Bioscience expects net proceeds of approximately $555,000 to fund general corporate purposes, including research and development, administrative expenses and working capital.
